Intriguingly, we observed an increase in glycolytic capacity and reserve following TGFβ2 treatment which was accompanied by an increased expression of glycolytic enzymes, PFKFB3, PKM2 and LDHA, linked to EMT in cancer metastasis models [34,35]. The gene discussed is TGFB2; the disease is cancer.